<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Retinoblastoma staging according to the American Joint Committee on Cancer 8&lt;sup&gt;th&lt;/sup&gt; edition tumor, node, metastasis (TNM) classification</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Retinoblastoma staging according to the American Joint Committee on Cancer 8<sup>th</sup> edition tumor, node, metastasis (TNM) classification</h1>
<div class="graphic"><div class="figure"><div class="ttl">Retinoblastoma staging according to the American Joint Committee on Cancer 8<sup>th</sup> edition tumor, node, metastasis (TNM) classification</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1_left" colspan="5">Clinical stage</td> </tr> <tr class="divider_bottom"> <td><strong>When primary tumor (cT) status is...</strong></td> <td><strong>And lymph node (cN) status is...</strong></td> <td><strong>And distant metastasis (M) status is...</strong></td> <td><strong>And heritable trait (H) status is...</strong></td> <td><strong>Then the clinical stage is...</strong></td> </tr> <tr> <td class="indent1">cT1, cT2, cT3</td> <td>cN0</td> <td>cM0</td> <td>Any</td> <td>Stage I</td> </tr> <tr> <td class="indent1">cT4a</td> <td>cN0</td> <td>cM0</td> <td>Any</td> <td>Stage II</td> </tr> <tr> <td class="indent1">cTb</td> <td>cN0</td> <td>cM0</td> <td>Any</td> <td>Stage III</td> </tr> <tr> <td class="indent1">Any</td> <td>cN1</td> <td>cM0</td> <td>Any</td> <td>Stage III</td> </tr> <tr class="divider_bottom"> <td class="indent1">Any</td> <td>Any</td> <td>cM1 or pM1</td> <td>Any</td> <td>Stage IV</td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="5">Definition of primary tumor (cT) – Based on the most advanced eye</td> </tr> <tr> <td class="indent1">cTX</td> <td colspan="4">Unknown evidence of intraocular tumor</td> </tr> <tr> <td class="indent1">cT0</td> <td colspan="4">No evidence of intraocular tumor</td> </tr> <tr> <td class="indent1">cT1</td> <td colspan="4">Intraocular tumor(s) with subretinal fluid ≤5 mm from the base of any tumor: <ul class="decimal_heading"> <li>cT1a – Tumors ≤3 mm and further than 1.5 mm from the disc and fovea</li> <li>cT1b – Tumors &gt;3 mm or closer than 1.5 mm to the disc and fovea</li> </ul> </td> </tr> <tr> <td class="indent1">cT2</td> <td colspan="4">Intraocular tumor(s) with retinal detachment, vitreous seeding or subretinal seeding: <ul class="decimal_heading"> <li>cT2a – Subretinal fluid &gt;5 mm from the base of any tumor</li> <li>cT2b – Tumors with vitreous seeding and/or subretinal seeding</li> </ul> </td> </tr> <tr> <td class="indent1">cT3</td> <td colspan="4">Advanced intraocular tumor(s): <ul class="decimal_heading"> <li>cT3a – Phthisis or pre-phthisis bulbi</li> <li>cT3b – Tumor invasion of the pars plana, ciliary body, lens, zonules, iris, or anterior chamber</li> <li>cT3c – Raised intraocular pressure with neovascularization and/or buphthalmos</li> <li>cT3d – Hyphema and/or massive vitreous hemorrhage</li> <li>cT3e – Aseptic orbital cellulitis</li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1">cT4</td> <td colspan="4">Extraocular tumor(s) involving the orbit, including the optic nerve: <ul class="decimal_heading"> <li>cT4a – Radiologic evidence of retrobulbar optic nerve involvement or thickening of the optic nerve or involvement of the orbital tissues</li> <li>cT4b – Extraocular tumor clinically evident with proptosis and orbital mass</li> </ul> </td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="5">Definition of regional lymph nodes (cN)</td> </tr> <tr> <td class="indent1">cNX</td> <td colspan="4">Regional lymph nodes cannot be assessed</td> </tr> <tr> <td class="indent1">cN0</td> <td colspan="4">No regional lymph nodes involvement</td> </tr> <tr class="divider_bottom"> <td class="indent1">cN1</td> <td colspan="4">Evidence of preauricular, submandibular, and cervical lymph node involvement</td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="5">Definition of distant metastasis (M)</td> </tr> <tr> <td class="indent1">cM0</td> <td colspan="4">No signs or symptoms of intracranial or distant metastasis</td> </tr> <tr> <td class="indent1">cM1</td> <td colspan="4">Distant metastasis without microscopic confirmation: <ul class="decimal_heading"> <li>cM1a – Tumor(s) involving any distant site (eg, bone marrow, liver) on clinical or radiologic tests</li> <li>cM1b – Tumor involving the CNS on radiologic imaging, not including pineoblastoma (ie, "trilateral" retinoblastoma)</li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1">pM1</td> <td colspan="4">Distant metastasis with microscopic confirmation: <ul class="decimal_heading"> <li>pM1a – Histopathologic confirmation of tumor at any distant site (eg, bone marrow, liver, or other)</li> <li>pM1b – Histopathologic confirmation of tumor in the cerebrospinal fluid or CNS parenchyma</li> </ul> </td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="5">Definition of heritable trait (H)</td> </tr> <tr> <td class="indent1">HX</td> <td colspan="4">Unknown or insufficient evidence of a germline <em>RB1</em> gene mutation</td> </tr> <tr> <td class="indent1">H0</td> <td colspan="4">Germline <em>RB1</em> gene mutation has been excluded (ie, based on genetic testing with a high-sensitivity assay)</td> </tr> <tr> <td class="indent1">H1</td> <td colspan="4">Known or presumed germline <em>RB1</em> gene mutation, based on <strong>any</strong> of the following: <ul class="decimal_heading"> <li>Bilateral retinoblastoma</li> <li>Retinoblastoma associated with an intracranial CNS midline embryonic tumor (ie, "trilateral" retinoblastoma)</li> <li>Patient has a family history of retinoblastoma</li> <li>Molecular diagnosis of germline <em>RB1</em> gene mutation</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes">CNS: central nervous system.</div><div class="graphic_reference">Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Corrected at 4th printing, 2018.</div><div id="graphicVersion">Graphic 131193 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
